Compare GRANULES INDIA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs GLAND PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA GLAND PHARMA GRANULES INDIA/
GLAND PHARMA
 
P/E (TTM) x 15.3 46.8 32.8% View Chart
P/BV x 3.4 9.4 35.9% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 GRANULES INDIA   GLAND PHARMA
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
GLAND PHARMA
Mar-21
GRANULES INDIA/
GLAND PHARMA
5-Yr Chart
Click to enlarge
High Rs4382,784 15.7%   
Low Rs1381,701 8.1%   
Sales per share (Unadj.) Rs130.7211.7 61.8%  
Earnings per share (Unadj.) Rs22.260.9 36.4%  
Cash flow per share (Unadj.) Rs28.367.0 42.3%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs86.8359.3 24.2%  
Shares outstanding (eoy) m247.67163.59 151.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.210.6 20.8%   
Avg P/E ratio x13.036.8 35.3%  
P/CF ratio (eoy) x10.233.5 30.4%  
Price / Book Value ratio x3.36.2 53.1%  
Dividend payout %6.80-   
Avg Mkt Cap Rs m71,337366,894 19.4%   
No. of employees `000NANA-   
Total wages/salary Rs m3,2433,114 104.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m32,37534,629 93.5%  
Other income Rs m2691,348 19.9%   
Total revenues Rs m32,64435,977 90.7%   
Gross profit Rs m8,55213,022 65.7%  
Depreciation Rs m1,515988 153.3%   
Interest Rs m26334 770.6%   
Profit before tax Rs m7,04413,348 52.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5493,378 45.9%   
Profit after tax Rs m5,4959,970 55.1%  
Gross profit margin %26.437.6 70.2%  
Effective tax rate %22.025.3 86.9%   
Net profit margin %17.028.8 58.9%  
BALANCE SHEET DATA
Current assets Rs m19,97051,236 39.0%   
Current liabilities Rs m11,7315,125 228.9%   
Net working cap to sales %25.4133.2 19.1%  
Current ratio x1.710.0 17.0%  
Inventory Days Days168 192.4%  
Debtors Days Days86371 1,220.2%  
Net fixed assets Rs m17,15713,724 125.0%   
Share capital Rs m248164 151.4%   
"Free" reserves Rs m21,26258,615 36.3%   
Net worth Rs m21,51058,778 36.6%   
Long term debt Rs m3,41139 8,671.7%   
Total assets Rs m37,12764,961 57.2%  
Interest coverage x27.8392.3 7.1%   
Debt to equity ratio x0.20 23,696.2%  
Sales to assets ratio x0.90.5 163.6%   
Return on assets %15.515.4 100.7%  
Return on equity %25.517.0 150.6%  
Return on capital %29.322.8 128.9%  
Exports to sales %81.983.8 97.8%   
Imports to sales %26.80-   
Exports (fob) Rs m26,52829,021 91.4%   
Imports (cif) Rs m8,691NA-   
Fx inflow Rs m26,52829,021 91.4%   
Fx outflow Rs m8,69116,878 51.5%   
Net fx Rs m17,83712,142 146.9%   
CASH FLOW
From Operations Rs m4,3256,049 71.5%  
From Investments Rs m-2,771-15,240 18.2%  
From Financial Activity Rs m-2,99312,385 -24.2%  
Net Cashflow Rs m-1,4413,230 -44.6%  

Share Holding

Indian Promoters % 41.6 0.0 -  
Foreign collaborators % 0.4 58.0 0.6%  
Indian inst/Mut Fund % 25.7 23.0 112.0%  
FIIs % 21.4 11.3 189.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 42.0 138.1%  
Shareholders   216,385 109,097 198.3%  
Pledged promoter(s) holding % 7.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

SGX Nifty Up 44 Points; Indicates Positive Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a positive note today. At 8:05 am, it was trading up by 44 points, or 0.3% higher at 17,148 levels.

Related Views on News

GLAND PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

Here's an analysis of the annual report of GLAND PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GLAND PHARMA. Also includes updates on the valuation of GLAND PHARMA.

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

Gland Pharma Q4 Results: Net Profit Rises 34%; Share Price Hits New 52-Week High (Views On News)

May 18, 2021

The new vaccine business is expected to accelerate the company's long-term strategy of entering into the biosimilar space.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

Top Indian Drone Companies to Watch Out for in 2022(Views On News)

Jan 21, 2022

Several companies are adopting drone technology for regular business operations.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


Jan 27, 2022 (Close)

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA 8-QTR ANALYSIS

COMPARE GRANULES INDIA WITH

MARKET STATS